Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
April 10, 2026
April 10, 2026
NEW BRUNSWICK, New Jersey, April 10 [Category: BizHealth & Beauty] -- Johnson and Johnson posted the following news release:
* * *
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
*
Jacksonville, FL, April 10, 2026 - Johnson & Johnson (NYSE: JNJ) will present data from two major studies supporting the performance of its recent . . .
* * *
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
*
Jacksonville, FL, April 10, 2026 - Johnson & Johnson (NYSE: JNJ) will present data from two major studies supporting the performance of its recent . . .
